
Explaining Clinical Trials
The European regulator explains what clinical trials are, why they are run in phases, and how participants are protected. A good baseline for reading…

The European regulator explains what clinical trials are, why they are run in phases, and how participants are protected. A good baseline for reading…

The FDA outlines key facts about how a new medicine moves from development to approval. It clarifies what regulators review and what an approval…
BreakthroughsKilling diseased cells in a dish is the easy part of drug development. This guide explains the evidence ladder, why most candidates fail, and seven questions to ask before believing a breakthrough headline.
BreakthroughsA positive Phase 1 result and a positive Phase 3 result sound similar but mean very different things. Here is what each stage of a clinical trial is designed to show, and what it cannot.
Companies + StocksMany biotech startups spend years building evidence rather than selling products. This map traces the stations most pass through, from licensing a discovery to the forks where companies partner, sell, go public or stop.
Companies + StocksBiotech companies tell two stories at once: one scientific, one financial. This educational guide, which is not investment advice, shows how to check primary sources like SEC EDGAR, ClinicalTrials.gov and FDA databases.
BreakthroughsHealth headlines often overstate early findings, sometimes before a journalist ever sees them. These seven questions help anyone judge a medical claim in about two minutes before sharing it.